SVB’s Megan Scheffel on Bio-Hope, the 2026 Landscape, and Longevity
About this episode
Megan Scheffel discusses the current state of healthcare investment and the convergence of longevity and consumer wellness.
Join us from San Francisco, as we sit down with Megan Scheffel, Head of Healthcare and Life Science at SVB. Megan breaks down the current state of healthcare investment, moving beyond the noise to focus on deal-making quality. We cover the rising bar for entrepreneurs, the convergence of longevity and consumer wellness, and AI's impact on patient data. Don't forget to subscribe to our Substack: https://substack.com/@digitalhealthroundtable
More episodes of The Digital Health Roundtable
- Uber Health at Scale with Allison Marsh
- Untangling the Data Maze:: Evidently's Vision with Kalie Dove-Maguire MD
- Siemens' Peter Shen on Varian's Role in Cancer Care, AI, and Precision Therapy
- Healthcare's Future with Philips: Shez Partovi MD, AI, and Integrated Diagnostics at HIMSS
- Tectonic Shifts in 2026 with Shez Partovi of Philips
- Innovative Care Solutions with Garner's Physician Network :: CTO Michi Kono
Explore listener stats, chart rankings, contacts and more on the The Digital Health Roundtable podcast page.